Stock listing

BCBA:AMGNB Amgen Inc. Acciones

Argentine listing (BCBA) of Amgen Inc. · home listing NASDAQ:AMGN

Follow Amgen Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:AMGN

$434.03 USD +7.92 (+1.9%)

Close on Oct 15, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:AMGN

Amgen Inc. logo
Ticker
BCBA:AMGNB
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
BCBA
Currency
ARS

What changed lately

Calls

Replays

  • Amgen (NASDAQ:AMGN) Q2 2026 Earnings Call

    Tue, Aug 04, 2026 · 4:30 PM ET

    Watch Transcript

  • Amgen (NASDAQ:AMGN) Q1 2026 Earnings Call

    Thu, Apr 30, 2026 · 4:30 PM ET

    Watch Transcript

  • Amgen (NASDAQ:AMGN) Q4 2025 Earnings Call

    Tue, Feb 03, 2026 · 4:30 PM ET

    Watch Transcript

Latest news

New twice-yearly maintenance dosing option for people living with generalized myasthenia gravis in Canada

Oct 13, 2026

Amgen announces positive topline Phase 3 results for dazodalibep in moderate-to-severe systemic Sjogren's disease

Sep 23, 2026

Amgen announces positive topline Phase 3 results for dazodalibep in moderate-to-severe systemic Sjögren's disease

Sep 22, 2026

FDA approves reduced monitoring time for first two doses of IMDELLTRA®

Sep 14, 2026

In the PAPILLON Study, First-Line Amivantamab-Chemotherapy Demonstrates the Longest Overall Survival Reported for EGFR Exon 20 Insertion-Positive Advanced NSCLC

Sep 14, 2026

Amgen to present at the morgan stanley 24th annual global healthcare conference

Sep 9, 2026

IMDELLTRA® in combination with imfinzi® demonstrated landmark improvement in overall survival in first-line extensive stage small cell lung cancer

Sep 8, 2026

Amgen to present at the 2026 wells fargo healthcare conference

Sep 2, 2026

Amgen's Repatha® reduces risk of death in patients at high risk for a first heart attack or stroke

Aug 31, 2026

TEZSPIRE® demonstrates positive Phase 3 results in eosinophilic esophagitis across both co-primary and all key secondary endpoints

Aug 27, 2026

All Amgen Inc. news

Decks

Amgen Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
75 in the last 12 months · 367 in all · newest Oct 13, 2026 · oldest 2019
Calls
29 calls with a replay · 29 with a transcript · latest Aug 4, 2026
Decks
25 decks · latest Aug 4, 2026

Where Amgen Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:AMGN · Home listingNASDAQUnited StatesUSD
gettex:AMGgettexGermanyEUR
BCBA:AMGNBCBAArgentinaARS
Xetra:AMGXetraGermanyEUR
SET:AMGN06SETThailandTHB
Tradegate:AMGTradegateGermanyEUR
TSX:AMGNTSXCanadaCAD
B3:AMGN34B3BrazilBRL
LS Exchange:867900LS ExchangeGermanyEUR
Cboe Canada:AMGNCboe CanadaCanadaCAD
BCBA:AMGNDBCBAArgentinaUSD
BMV:AMGNBMVMexicoMXN
Stuttgart:AMGStuttgartGermanyEUR
Milan:1AMGNMilanItalyEUR
Lang & Schwarz:867900Lang & SchwarzGermanyEUR
BCS:AMGNCLBCSChileCLP
Frankfurt:AMGFrankfurtGermanyEUR
BOATS:AMGNBOATSUnited StatesUSD
BIVA:AMGNBIVAMexicoMXN
HKEX:4332HKEXHong KongHKD
BCBA:AMGNB · This pageBCBAArgentinaARS
BX Swiss:AMGBX SwissSwitzerlandCHF
LSE:0R0TLSEUnited KingdomUSD
Dusseldorf:AMGDusseldorfGermanyEUR
Aquis:AMGDAquisUnited KingdomEUR
EUROTLX:4AMGNEUROTLXItalyEUR
Hamburg:AMGHamburgGermanyEUR
Munich:AMGMunichGermanyEUR
Hanover:AMGHanoverGermanyEUR
Turquoise:AMGNNTurquoiseUnited KingdomUSD
Aquis:AMGDAquisUnited KingdomEUR
VIE:AMGNViennaAustriaEUR
BCBA:AMGCBBCBAArgentinaUSD
BCBA:AMGDBBCBAArgentinaUSD
BCBA:AMGNCBCBAArgentinaUSD
Frankfurt:AMG0FrankfurtGermanyEUR
BCS:AMGNBCSChileUSD
BCBA:AMGN.CIBCBAArgentinaARS

Log in to ask 6ix AI your own questions about Amgen Inc.